Medical & Reimbursement Policies
Search
Contact Us
Provider Resources
Archived Policies
Provider Notifications
Medication Policies
Home
Medication Policies
Medication Policies
ALPHA 1 PROTEINASE INHIBITORS
AMVUTTRA
BOTULINUM TOXINS
CHIMERIC ANTIGEN RECEPTOR T CELL (CAR-T) IMMUNOTHERAPY
CYTOKINE AND CAM
DUCHENNE MUSCULAR DYSTROPHY (DMD)
ERYTHROPOIESIS STIMULATING AGENTS
FABRY DISEASE MEDICATIONS
GENE THERAPY AGENTS
IMMUNE GLOBULINS
LANTIDRA (DONISLECEL-JUJU)
LUTATHERA (LUTETIUM LU 177 DOTATATE)
LUXTURNA (VORETIGENE NEPARVOVEC-RZYL)
MEDICAL DRUGS
MEDICAL STEP THERAPY
NATALIZUMAB
QALSODY
RITUXAN AND BIOSIMILARS
RYSTIGGO (ROZANOLIXIZUMAB-NOLI)
SANDOSTATIN LAR DEPOT
YCANTH (CANTHARIDIN)
ZOLGENSMA (ONASEMNOGENE ABEPARVOVEC-XIOI)
ZULRESSO